Clinical studies also show that levels of inflammatory factors (IL-6) and oxidative stress markers (SOD, MDA, NOS) in patients with PD are significantly higher than healthy controls (Nagatsu et al., 2000). This evidence concerns the gene IL6 and Parkinson disease.